跳转至内容
Merck
CN

SML2768

Vicriviroc Maleate

≥98% (HPLC)

别名:

(4,6-Dimethyl-5-pyrimidinyl)[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methyl-1-piperidinyl]methanone Maleate, MK 7690, SCH 417690, SCH-D

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C28H38F3N5O2·C4H4O4
化学文摘社编号:
分子量:
649.70
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI

1S/C28H38F3N5O2.C4H4O4/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3;5-3(6)1-2-4(7)8/h6-9,18-19,24H,10-17H2,1-5H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t19-,24-;/m0./s1

SMILES string

O=C(/C=C\C(O)=O)O.FC(F)(F)C(C=C1)=CC=C1[C@H](COC)N([C@@H](C)C2)CCN2C(CC3)(C)CCN3C(C4=C(C)N=CN=C4C)=O

InChI key

GXINKQQWHLIBJA-UCIBKFKQSA-N

assay

≥98% (HPLC)

form

powder

storage condition

desiccated

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

−20°C

Quality Level

Biochem/physiol Actions

Inhibitor of chemokine CCR5 receptors; Antiretroviral entry inhibitor
Vicriviroc is an orally available, potent and selective allosteric antagonist of C-C chemokine CCR5 receptors. Vicriviroc inhibits the interaction of HIV-1 with CCR5 receptor thereby preventing HIV-1 virus entry into cells.

存储类别

11 - Combustible Solids

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Reem Berro et al.
Journal of virology, 87(12), 6569-6581 (2013-03-08)
Small-molecule CCR5 inhibitors such as vicriviroc (VVC) and maraviroc (MVC) are allosteric modulators that impair HIV-1 entry by stabilizing a CCR5 conformation that the virus recognizes inefficiently. Viruses resistant to these compounds are able to bind the inhibitor-CCR5 complex while
Paul McNicholas et al.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 55(2), 134-139 (2012-07-25)
Vicriviroc (VCV), a small-molecule antagonist of the C-C chemokine receptor 5 (CCR5), blocks HIV's entry into CD4+ cells. Small studies have suggested that resistance to CCR5 antagonists is slow to develop. To examine resistance to VCV in isolates from treatment
Xuanmao Jiao et al.
Cancer research, 78(7), 1657-1671 (2018-01-24)
The functional significance of the chemokine receptor CCR5 in human breast cancer epithelial cells is poorly understood. Here, we report that CCR5 expression in human breast cancer correlates with poor outcome. CCR5+ breast cancer epithelial cells formed mammospheres and initiated

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持